Frontlight ResearchEarly access
Trial site
Shanghai Liquan Hospital
- 8running trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Childhood cancers6 trials
- Acute lymphoblastic leukaemia3 trials
- Multiple myeloma2 trials
- Acute myeloid leukaemia1 trial
- Phase
- Phase 1/25 trials
- Phase 13 trials
- Status
- Recruiting7 trials
- Not yet recruiting1 trial
- Lead sponsor
- Beijing GoBroad Hospital8 trials
Running trials
Recruiting
Recruiting
Recruiting
Dual-target BCMA-GPRC5D CAR-T Cell Therapy for RR/MM With Extramedullary Infiltration
Recruiting
Dual-target BCMA-CD19 CAR-T Cell Therapy for RR/MM With Extramedullary Infiltration
Recruiting
Recruiting
Recruiting
Optimised CD33 (FL-33) CAR T Therapy for Refractory/Relapsed Acute Myeloid Leukaemia
Recruiting
Autologous and Donor-derived CD7 CAR-T Therapy in Refractory or Relapsed T-cell Malignancies
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers6 recruiting
- Acute lymphoblastic leukaemia3 recruiting
- Multiple myeloma2 recruiting
- Acute myeloid leukaemia1 recruiting
Site data: ClinicalTrials.govUpdated 12 Nov 2026